Creative Medical Technology Holdings, Inc.
CELZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001187953
No open-market purchases or sales by Creative Medical Technology Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $540.7K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Creative Medical Technology Holdings, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 15 | 15 | 0 |
| Shares | 188.0K | 1.51M | +1.32M (+702.0%) |
| Value | $734.0K | $1.13M | +$397.0K (+54.1%) |
New holders (5)
Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 1,244,175 | $933.0K | 0.02% |
| Boothbay Fund Management, LLC | 88,889 | $67.0K | 0.00% |
| Geode Capital Management, LLC | 34,338 | $25.0K | 0.00% |
| Northern Trust Corp | 10,018 | $8.00K | 0.00% |
| Advisor Group Holdings, Inc. | 12 | $0 | 0.00% |
Sold out (5)
Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Sassicaia Capital Advisers LLC | 31,200 | $122.0K |
| Schonfeld Strategic Advisors LLC | 21,600 | $84.0K |
| XTX Topco Ltd | 17,493 | $68.0K |
| Two Sigma Securities, LLC | 13,263 | $52.0K |
| UBS Group AG | 9,160 | $36.0K |